The Pennant Group’s (PNTG) “Overweight” Rating Reiterated at Stephens

Stephens restated their overweight rating on shares of The Pennant Group (NASDAQ:PNTGFree Report) in a report published on Tuesday,Benzinga reports. The brokerage currently has a $35.00 price objective on the stock.

A number of other brokerages also recently issued reports on PNTG. Wells Fargo & Company increased their price target on The Pennant Group from $30.00 to $31.00 and gave the stock an “equal weight” rating in a research report on Tuesday, June 3rd. Truist Financial raised their target price on The Pennant Group from $28.00 to $32.00 and gave the company a “hold” rating in a report on Monday, May 12th. Two equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $34.60.

View Our Latest Analysis on PNTG

The Pennant Group Trading Up 0.3%

Shares of NASDAQ:PNTG opened at $27.74 on Tuesday. The company has a market capitalization of $956.17 million, a P/E ratio of 40.79, a P/E/G ratio of 2.24 and a beta of 1.51. The Pennant Group has a 1 year low of $21.18 and a 1 year high of $37.13. The company has a debt-to-equity ratio of 0.58, a current ratio of 1.12 and a quick ratio of 1.12. The business’s 50 day simple moving average is $27.28 and its 200 day simple moving average is $26.81.

Insider Buying and Selling at The Pennant Group

In related news, Director Joanne Stringfield sold 5,000 shares of the business’s stock in a transaction on Tuesday, May 20th. The stock was sold at an average price of $29.47, for a total transaction of $147,350.00. Following the sale, the director now owns 30,275 shares in the company, valued at $892,204.25. The trade was a 14.17% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Company insiders own 5.40% of the company’s stock.

Institutional Investors Weigh In On The Pennant Group

Hedge funds and other institutional investors have recently bought and sold shares of the company. NBC Securities Inc. bought a new stake in The Pennant Group during the 1st quarter worth $25,000. Turtle Creek Asset Management Inc. grew its position in The Pennant Group by 150.0% during the 4th quarter. Turtle Creek Asset Management Inc. now owns 2,500 shares of the company’s stock worth $66,000 after acquiring an additional 1,500 shares during the last quarter. Quarry LP grew its position in The Pennant Group by 166.8% during the 4th quarter. Quarry LP now owns 2,705 shares of the company’s stock worth $72,000 after acquiring an additional 1,691 shares during the last quarter. Summit Investment Advisors Inc. grew its position in The Pennant Group by 20.3% during the 4th quarter. Summit Investment Advisors Inc. now owns 3,414 shares of the company’s stock worth $91,000 after acquiring an additional 575 shares during the last quarter. Finally, Public Employees Retirement Association of Colorado acquired a new position in The Pennant Group during the 4th quarter worth about $122,000. Institutional investors own 85.88% of the company’s stock.

About The Pennant Group

(Get Free Report)

The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.

Read More

Analyst Recommendations for The Pennant Group (NASDAQ:PNTG)

Receive News & Ratings for The Pennant Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Pennant Group and related companies with MarketBeat.com's FREE daily email newsletter.